Anzeige
Mehr »
Sonntag, 15.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
323 Leser
Artikel bewerten:
(1)

FactMR: Blood Collection Tubes for Liquid Biopsy Market to Expand at 6% CAGR Through 2029; Non-invasive Screening Key Application Area, Says Fact.MR

Favorable reimbursement policies and better healthcare facilities are key factors contributing towards the growth in demand for blood collection tubes for liquid biopsy.

DUBLIN, IRELAND / ACCESSWIRE / February 25, 2020 / The global blood collection tubes for liquid biopsy market is set to rise at a healthy CAGR of 6% between 2019 and 2029, according to the projections of a new study by Fact.MR. Leading manufacturers of blood collection tubes for liquid biopsy are investing efforts in direct sale distribution channels and more effective promotional strategies.

"The healthcare industry is consistently witnessing an increase in the number of biopsy procedures every year, due to the high prevalence of cancer. This, in turn, has led to the growth of the blood collection tubes for liquid biopsy market, which has aided in early diagnosis of cancer," says the Fact.MR report.

Request PDF Sample of 170 pages report on the blood collection tubes for liquid biopsy market-

https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Blood Collection Tubes for Liquid Biopsy Market Study: Key Findings

  • Plastic versions of blood collection tubes for liquid biopsy is projected to gain consumer preference over glass alternatives.
  • The market is at a nascent stage, and the scope for application remains largely limited to the global research industry.
  • Developed regional markets continue to flourish on the back of high product accessibility.
  • Sophistication of the medical infrastructure and increasing affordability of healthcare product supports market growth in East and South Asian countries.

Blood Collection Tubes for Liquid Biopsy Market: Key Driving Factors

  • Healthcare centers are displaying a substantial increase in the adoption of blood collection tubes for liquid biopsy to meet research needs.
  • Rising prevalence of cancers is a major factor driving the growth of the blood collection tubes for biopsy market.
  • The rising demand for single needle penetration practices for multiple tests will promote the use of blood collection tubes.

Explore 148 figures, 52 tables in the study. Request TOC of the report at-

https://www.factmr.com/report/4495/blood-collection-tubes-for-liquid-biopsy-market

Key Blood Collection Tubes for Liquid Biopsy Market: Key Restraints

  • Ineffective treatment methods and the resultant false negatives and positives lead to the use of inappropriate treatments, hampering market growth.

Competition Landscape

The global blood collection tubes for liquid biopsy market is moderately fragmented. Industry leaders are focusing their efforts on conventional blood collection tubes for liquid biopsy offerings. Companies are also focusing on improving their customer reach through direct sales operations via multiple distribution channels. The report provides a detailed analysis of the profiles and strategic developments of key players in the global blood collection tubes for liquid biopsy market, which include but are not limited to, La Roche Ltd., Biomatrica, Qiagen, Biocept Inc., Streck Inc., and Norgen Biotek.

About the Report

This 170-page study provides in-depth forecast data on the blood collection tubes for liquid biopsy market. The key categories covered by the report include product material (plastic and glass), application (IVD and Research Use), end user (healthcare centers, research and development centers, and diagnostic centers) and 25+ countries in key regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Explore Fact.MR's Detailed Coverage of the Healthcare Landscape

Breast Localization Needles Market-The report on breast localization needles covers opportunities for the manufacturers of breast localization needles and analyzes the value chain analysis in detail.

Tracheostomy Equipment Package Market- The report discusses the revenue generated from sales of tracheostomy equipment packages across all key regional economies.

Genitourinary Cancers Treatment Market-The genitourinary cancers treatment market has been assessed in the report on the basis of sales and pricing figures by treatment types.

About Fact.MR

Expert analysis, actionable insights, and strategic recommendations of the veteran research team at Fact.MR helps clients from across the globe with their unique business intelligence requirements. With a repository of over thousand reports and 1 million+ data points, the team has scrutinized the Healthcare sector across 50+ countries for over a decade. The team provides unmatched end-to-end research and consulting services. Reach out to explore how we can help.

Contact:

Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai, United Arab Emirates
MARKET ACCESS DMCC Initiative
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog - https://blog.factmr.com/
PR- https://www.factmr.com/media-release/1275/global-blood-collection-tubes-for-liquid-biopsy-market

SOURCE: FactMR



View source version on accesswire.com:
https://www.accesswire.com/577759/Blood-Collection-Tubes-for-Liquid-Biopsy-Market-to-Expand-at-6-CAGR-Through-2029-Non-invasive-Screening-Key-Application-Area-Says-FactMR

© 2020 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.